1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Angiosarcoma Global Clinical Trials Review, H1, 2015

Angiosarcoma Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 78 pages

Angiosarcoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2015" provides data on the Angiosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angiosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Angiosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Angiosarcoma Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Angiosarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Angiosarcoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Angiosarcoma to Oncology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Angiosarcoma 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Angiosarcoma Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Threshold Pharmaceuticals, Inc. 29
Clinical Trial Overview of Threshold Pharmaceuticals, Inc. 29
Bayer AG 30
Clinical Trial Overview of Bayer AG 30
Merck and Co., Inc. 31
Clinical Trial Overview of Merck and Co., Inc. 31
Daiichi Sankyo Company, Limited 32
Clinical Trial Overview of Daiichi Sankyo Company, Limited 32
Clinical Trial Overview of Top Institutes / Government 33
National Cancer Institute 33
Clinical Trial Overview of National Cancer Institute 33
University of Heidelberg 34
Clinical Trial Overview of University of Heidelberg 34
European Organization for Research and Treatment of Cancer 35
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 35
Northwestern University 36
Clinical Trial Overview of Northwestern University 36
Centre Oscar Lambret 37
Clinical Trial Overview of Centre Oscar Lambret 37
Ehime University Graduate School of Medicine 38
Clinical Trial Overview of Ehime University Graduate School of Medicine 38
National Cancer Center Hospital 39
Clinical Trial Overview of National Cancer Center Hospital 39
University Health Network 40
Clinical Trial Overview of University Health Network 40
Fox Chase Cancer Center 41
Clinical Trial Overview of Fox Chase Cancer Center 41
Memorial Sloan Kettering Cancer Center 42
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 42
Five Key Clinical Profiles 43
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables
Angiosarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Angiosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Angiosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Angiosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Angiosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Angiosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Angiosarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Angiosarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Angiosarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Angiosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Angiosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Angiosarcoma Therapeutics, Global, Suspended Clinical Trials, 2015* 22
Angiosarcoma Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Angiosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Angiosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Angiosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Angiosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Angiosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2015* 29
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 30
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 31
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 32
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 33
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2015* 34
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 35
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 36
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2015* 37
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ehime University Graduate School of Medicine, 2015* 38
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2015* 39
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 40
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 41
Angiosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 42

List of Figures
Angiosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Angiosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Angiosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Angiosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Angiosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Angiosarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Angiosarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Angiosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Angiosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Angiosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Angiosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Angiosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Angiosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Angiosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Angiosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in the US and the UK

  • December 2016
    12 pages
  • Pathology  

    Digestive Syste...  

    Cancer  

  • United States  

    United Kingdom  

View report >

Pathology Statistics in the US and the UK

  • December 2016
    13 pages
  • Pathology  

    Digestive Syste...  

  • United States  

    United Kingdom  

View report >

Cancer Statistics in Europe - Forecast

  • December 2016
  • Cancer  

  • Europe  

    World  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.